Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Cancer Therapy
Breast cancer angiogenesis declined in response to resveratrol
March 9th, 2006
Breast cancer angiogenesis declined in response to resveratrol. According to a study from Sweden, "Resveratrol, a polyphenol found in grapes and wine, is considered a potential cancer chemopreventive agent. Resveratrol has been shown to induce transcription via both estrogen receptor (ER)alpha and ERbeta." "We observed significantly lower tumor growth, decreased angiogenesis, and increased apoptotic index in ERalpha- ERbeta+ MDA-MB-231 tumors in resveratrol-treated nude mice compared with controls," reported S. Garvin and colleagues, Linkoping University Hospital. "In vitro we found a significant increase in apoptosis in...
Source: Women's Health Weekly (2006-03-09)
|
